» Articles » PMID: 34732318

C-Reactive Protein, a Promising Approach for Acetaminophen Hepatotoxicity

Overview
Specialty Gastroenterology
Date 2021 Nov 4
PMID 34732318
Authors
Affiliations
Soon will be listed here.
References
1.
Torres S, Baulies A, Insausti-Urkia N, Alarcon-Vila C, Fucho R, Solsona-Vilarrasa E . Endoplasmic Reticulum Stress-Induced Upregulation of STARD1 Promotes Acetaminophen-Induced Acute Liver Failure. Gastroenterology. 2019; 157(2):552-568. DOI: 10.1053/j.gastro.2019.04.023. View

2.
Andrade R, Chalasani N, Bjornsson E, Suzuki A, Kullak-Ublick G, Watkins P . Drug-induced liver injury. Nat Rev Dis Primers. 2019; 5(1):58. DOI: 10.1038/s41572-019-0105-0. View

3.
Fernandez-Checa J, Bagnaninchi P, Ye H, Sancho-Bru P, Falcon-Perez J, Royo F . Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]. J Hepatol. 2021; 75(4):935-959. DOI: 10.1016/j.jhep.2021.06.021. View

4.
Win S, Than T, Min R, Aghajan M, Kaplowitz N . c-Jun N-terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)-dependent pathway leading to inactivation of intramitochondrial Src. Hepatology. 2016; 63(6):1987-2003. PMC: 4874901. DOI: 10.1002/hep.28486. View

5.
Li H, Tang Z, Wang Z, Lv J, Liu X, Liang Y . C-Reactive Protein Protects Against Acetaminophen-Induced Liver Injury by Preventing Complement Overactivation. Cell Mol Gastroenterol Hepatol. 2021; 13(1):289-307. PMC: 8599171. DOI: 10.1016/j.jcmgh.2021.09.003. View